Fondita European Small Cap

Europe's smaller companies that have already succeeded in their internationalisation efforts

Our funds
The fund

Fondita European Small Cap is an equity fund that invests in a limited number of small and medium-sized European quality companies with a market capitalisation of up to EUR 4 billion. The fund has a concentrated portfolio and invests in companies, whose long-term growth is mainly driven by structural factors and societal changes.

Small caps

The fund invests in small caps that have already succeeded and can showcase a business model that works internationally. The small cap segment holds many family-owned companies that have gone from being local champions to bringing their know-how to the world.

Such companies focus on demographic changes in terms of both individual health and well-being, as well as changing consumer behaviours, the widespread digitisation of society, an increased focus on the environment and climate, and the manufacturing industry’s progress towards increasingly automated processes.

These are smaller listed companies that have shown stronger growth and greater potential. They often have both their own niche and a solid market position resulting in strong profitability.

Sustainability
Read more about the fund’s sustainability principles:
Fund facts

31.8.2023

Fund size (M€)
52,8
ISIN (A)
FI0008814686
ISIN (B)
FI0008814694
Currency
EUR
Management fee
2,00 % p.a.
Risk indicator
5/7
SFDR Classification
Article 8
Top holdings
Siegfried Holding (DE)
5,5 %
Kontron (AT)
4,7 %
Dermapharm Holding (DE)
4,6 %
Laboratorios Frama Rovi (ES)
4,2 %
All for One Group (DE)
4,1 %
Germany
24 %
Sweden
18 %
Switzerland
15 %
Great Britain
6 %
Italy
6 %
Return
1 month
-4,2 %
3 months
-5,1 %
6 months
-8,8 %
YTD
-2,3 %
1 year
-7,8 %
3 years
4,9 %
5 years
-3,8 %
10 years
66,5 %
since launch (19.5.2009)
242,2 %
since launch p.a.
9,0 %
Sector division
Information Technology
31 %
Industrials
29 %
Health Care
22 %
Materials
5 %
Consumer discretionary
5 %
Energy
3 %
Other
5 %
Top 10 holdings
Siegfried Holding (DE)
5,5 %
Kontron (AT)
4,7 %
Dermapharm Holding (DE)
4,6 %
Laboratorios Frama Rovi (ES)
4,2 %
All for One Group (DE)
4,1 %
Bufab (SE)
4,0 %
Inficon Holding (CH)
3,7 %
Adesso (DE)
3,5 %
Borregaard (NO)
3,4 %
Discoverie Group (GB)
3,4 %
Country division
Germany
24 %
Sweden
18 %
Switzerland
15 %
Great Britain
6 %
Italy
6 %
Norway
6 %
Other
25 %
Currency exposure
EUR
52 %
SEK
18 %
CHF
15 %
GBP
6 %
NOK
6 %
DKK
3 %
Fees
TER
2,00 %
Subscription fee
0,00 %
Redemption fee
1,00 %

Total client relationship allow for changes in tariff rate.

Documents

FUND INFORMATION
KID
PAI Statements
Fund rules
Prospectus
REPORTS
Monthly report
Annual report
SUSTAINABILITY DOCUMENTS
ESG Report
Responsible Investment Policy
Exclusion list

This is marketing communication. The past performance of the investment fund does not provide any guarantee of future results. Read the fund prospectus and KID (Key Information Document) before making any investment decisions. The fund prospectus and KID are available on English, Finnish and Swedish at our website.

Our funds
Latest news
Europe’s sick patient, Germany, is far healthier than feared

In September I travelled to Munich to participate in Berenberg’s 12th German corporate seminar. The goal of the trip was not to ... Read more

Fondita Finland Micro Cap – A very strong performance in a challenging market

The Fondita Finland Micro Cap fund has had a very impressive 2023 so far although the market environment has been challenging, mainly ... Read more

Web design: Wikström Media
Fondita online Fondita
online